People who use drugs
141 articles
Harm Reduction in Europe: Histories, Choices and Hopes
Harm Reduction Journal releases a thematic series on harm reduction, providing a comprehensive and insightful look into the journey of harm reduction across the diverse regions of Europe. More
European Cities on the Frontline: Harm Reduction and Drug Policy – Needs, Best Practices and Recommendations
C-EHRN releases a report underlining the crucial role of municipal leadership, cross-sectoral cooperation, and community engagement in building resilient harm reduction responses. More
Development Dimensions of Drug Policy: Assessing New Challenges, Uncovering Opportunities, and Addressing Emerging Issues
UNDP releases a discussion paper examining how drug policy affects sustainable development, human rights, governance, health, and the environment. More
The BOOST Project: A Series of Policy Briefs
The BOOST project supports and strengthens community-based and community-led organisations in Europe in providing communicable diseases services as part of comprehensive, people-centred harm reduction strategies. More
Is 4 Weeks of Glecaprevir/Pibrentasvir Sufficient to Treat Early Hepatitis C Infection?
A 4-week course of glecaprevir/pibrentasvir achieved sustained virologic response in 84% of patients with early HCV infection in the PURGE-C trial, suggesting potential for shorter, more accessible treatment regimens pending further validation. More
